In carbamate poisoning all the following should be administered except :
Carbamates inhibit acetylcholinesterase, leading to cholinergic crisis. The standard treatment includes atropine and pralidoxime (2-PAM) to reverse the effects. But wait, pralidoxime isn't used in carbamate poisoning because the inhibition is reversible. So maybe the incorrect option is pralidoxime?
Wait, the question asks which should NOT be administered. The correct answer would be pralidoxime. Let me confirm. Carbamates cause a non-covalent inhibition of AChE, so the enzyme can recover on its own. Pralidoxime is used in OP poisoning to reactivate the enzyme. Therefore, administering pralidoxime in carbamate poisoning is unnecessary and possibly harmful. That makes pralidoxime the exception here.
Looking at the options: if one of them is pralidoxime, that's the correct answer. The other options might include atropine, which is correct, and maybe others like activated charcoal or supportive care. The incorrect options (A, B, C) would be the ones that are actually used. So the answer is D if pralidoxime is option D.
Now, structure the explanation. Start with the core concept about cholinergic crisis and treatment differences between OP and carbamates. Then explain why pralidoxime is wrong. For each wrong option, state why they are correct. The clinical pearl would be that pralidoxime isn't used in carbamate poisoning. Make sure the correct answer is labeled properly.
**Core Concept**
Carbamate poisoning causes reversible acetylcholinesterase (AChE) inhibition, leading to cholinergic overstimulation. Unlike organophosphorus compounds, carbamates do not form a stable, irreversible AChE complex, necessitating distinct treatment approaches.
**Why the Correct Answer is Right**
Pralidoxime (2-PAM) reactivates AChE by breaking the phosphorus-AChE bond in organophosphate poisoning. However, in carbamate poisoning, the AChE inhibition is transient and self-reversible. Administering pralidoxime here is ineffective and unnecessary, as it does not bind to the carbamate-AChE complex. This makes pralidoxime the exception in treatment protocols.
**Why Each Wrong Option is Incorrect**
**Option A:** Atropine is correct—it competitively antagonizes acetylcholine at muscarinic receptors, counteracting cholinergic crisis.
**Option B:** Activated charcoal is correct—it adsorbs ingested toxins, preventing systemic absorption.
**Option C:** Supportive care (e.g., airway management) is correct—it addresses life-threatening symptoms like bronchorrhea or seizures.
**Clinical Pearl / High-Yield Fact**
Remember: *"Carbamate = No PAM!"* Pralidoxime is contraindicated in carbamate poisoning. Use atropine and supportive care instead, as AChE recovers rapidly without reactivators. Avoid exam traps that confuse OP and carbamate management.
**Correct Answer: D.